MK-0773

DB16244InvestigationalSmall molecule

MK-0773 is under investigation in clinical trial NCT00529659 (A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(mk-0773-005)).

Mechanism: Pharmacologically active on Androgen receptor
Curator reviewed
Formula / weight: C₂₇H₃₄FN₅O₂ · 479.6 g/mol (avg)
Code names: MK-0773 · PF-05314882

Resolves to

Compound

UNII5730VNW22XCAS606101-58-0ChEMBLCHEMBL3221237

Structure

InChIKeyGBEUKTWTUSPHEE-JWJWXJQQSA-NSMILES[H][C@@]12CC[C@H](C(=O)NCC3=NC4=C(N3)C=CC=N4)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])N(C)C(=O)C(F)=C[C@]12C

Targets

P10275AR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with MK-0773, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account